Rayner Surgical Group Limited Sustainability Profile
Rayner Surgical Group Limited, commonly known as Rayner, is a leading British ophthalmic company headquartered in GB. Founded in 1910, Rayner has established itself as a pioneer in the field of eye care, particularly in the development of innovative intraocular lenses and surgical solutions. With a strong presence in Europe, Asia, and the Americas, the company has achieved significant milestones, including the introduction of the first-ever foldable intraocular lens. Rayner's core offerings include a range of advanced intraocular lenses, surgical instruments, and diagnostic equipment, all designed to enhance patient outcomes and streamline surgical procedures. Renowned for their commitment to quality and innovation, Rayner has positioned itself as a trusted partner in the ophthalmic industry, consistently delivering products that meet the evolving needs of eye care professionals.
DitchCarbon Score
How does Rayner Surgical Group Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Rayner Surgical Group Limited's score of 24 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Rayner Surgical Group Limited's reported carbon emissions
In 2024, Rayner Surgical Group Limited reported total carbon emissions of approximately 12,326,000 kg CO2e. This figure includes Scope 1 emissions of about 714,000 kg CO2e, Scope 2 emissions of around 1,080,000 kg CO2e, and a significant contribution from Scope 3 emissions, which totalled approximately 10,532,000 kg CO2e. Comparatively, in 2021, the company recorded total emissions of about 25,109,000 kg CO2e, indicating a notable reduction in emissions over the years. The breakdown for 2021 included Scope 1 emissions of approximately 763,000 kg CO2e, Scope 2 emissions of about 1,077,000 kg CO2e, and Scope 3 emissions of around 23,926,000 kg CO2e. Despite these reductions, Rayner Surgical Group Limited has not set specific science-based targets (SBTi) or documented reduction initiatives as part of their climate commitments. The company has not disclosed any climate pledges or formal reduction targets, which may limit their strategic approach to addressing climate change. Overall, while Rayner Surgical Group Limited has made progress in reducing its carbon footprint, further commitments and structured targets could enhance its climate strategy and align it with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 763,000 | - | 000,000 |
| Scope 2 | 1,077,000 | 000,000 | 0,000,000 |
| Scope 3 | 23,926,000 | 0,000,000 | 00,000,000 |
How Carbon Intensive is Rayner Surgical Group Limited's Industry?
How Carbon Intensive is Rayner Surgical Group Limited's Location?
Rayner Surgical Group Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Rayner Surgical Group Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
